Back
Arcellx Vs. NovoCure Industry Stock Comparison
Sell
18
ACLX
Arcellx
Last Price:
$77.47
Seasonality Move:
14.38%
Sell
49
NVCR
NovoCure
Last Price:
$30.93
Seasonality Move:
-8.57%
Sell
49
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ACLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.36 | Sell |
Relative Strength Index (14 RSI): | 39 | Sell |
Chaikin Money Flow: | 187660 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (79.44 - 89.9) | Sell |
Bollinger Bands (100): | (68.81 - 91.91) | Sell |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.02 | Buy |
Relative Strength Index (14 RSI): | 64.15 | Buy |
Chaikin Money Flow: | 291530 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.5 - 32.28) | Buy |
Bollinger Bands (100): | (14.36 - 24.58) | Buy |
ACLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 78.74 | Sell |
20-day SMA: | 83.74 | Sell |
50-day SMA: | 88.16 | Sell |
200-day SMA: | 69.09 | Buy |
8-day EMA: | 78.62 | Sell |
20-day EMA: | 82.39 | Sell |
50-day EMA: | 84.25 | Sell |
200-day EMA: | 71.94 | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.43 | Sell |
20-day SMA: | 28.64 | Buy |
50-day SMA: | 21.62 | Buy |
200-day SMA: | 18.41 | Buy |
8-day EMA: | 30.72 | Buy |
20-day EMA: | 28.28 | Buy |
50-day EMA: | 23.76 | Buy |
200-day EMA: | 20.64 | Buy |
Arcellx Earnings Growth & ACLX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and a decrease next year of $0.73 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.31 per share.
Arcellx Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |